Azitra, Inc.
Developing engineered proteins and live biotherapeutics for rare skin diseases.
AZTR | US
Overview
Corporate Details
- ISIN(s):
- US05479L2034
- LEI:
- Country:
- United States of America
- Address:
- 21 BUSINESS PARK DRIVE, SUITE 6, 6405 BRANFORD
- Website:
- https://azitrainc.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Azitra, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology. The company utilizes its proprietary platform, combining genetic engineering, proteomics, and skin microbiome science, to create novel treatments for skin diseases. Azitra's approach centers on developing engineered proteins and live biotherapeutic products (LBPs) designed to deliver therapeutic proteins directly to the skin. The product pipeline includes candidates targeting rare and underserved conditions such as Netherton syndrome (ATR-12), EGFR inhibitor-associated rash (ATR-04), and ichthyosis vulgaris (ATR-01).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Azitra, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Azitra, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Azitra, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
